{
  "id": "SCR-LIP-000627",
  "statement": "Lipedema and lipedema-like peripheral fat distribution may be associated with greater insulin sensitivity than comparable obesity, though findings are mixed.",
  "claim_type": "clinical_association",
  "context": {
    "population": "US women >=20y (NHANES)",
    "condition": "lipedema",
    "exposure": "lipedema-like phenotype (LTR >90th pct)",
    "comparator": "controls (LTR <=90th pct)",
    "outcome": "HOMA-IR, NLR",
    "scope": "cross-sectional, n=283 phenotype / 3550 controls"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "moderate",
  "evidence": [
    {
      "ref": "DOI:10.64898/2025.12.01.25341350",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": 3833,
      "risk_of_bias": "moderate",
      "year": 2025,
      "amato_authored": true,
      "note": "exploratory; DXA proxy may capture gynoid obesity",
      "title": "The Lipedema Phenotype is Inversely Associated with Celiac Disease Autoimmunity: Testing the Immunological Shield Hypothesis in NHANES",
      "authors": "Amato et al.",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly reports HOMA-IR 44.2% lower in the lipedema phenotype group (1.35 vs 2.42, p<0.001) and NLR 7.6% lower (1.96 vs 2.12, p=0.012) in NHANES women, matching the statement exactly.",
        "date": "2026-06-10"
      },
      "quote": "HOMA-IR mediano 44,2% menor no fenótipo lipedema (1,35 [IQR 0,95–2,01] vs 2,42 [IQR 1,47–4,30]; p<0,001)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In NHANES women, a DXA-defined lipedema-like phenotype (leg-to-trunk fat ratio >90th percentile, not diagnosed lipedema) had 44.2% lower median HOMA-IR (p<0.001) than other women, not obesity-matched.",
      "from_claims": [
        "SCR-LIP-000027"
      ]
    },
    {
      "ref": "DOI:10.2337/db24-0890",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2025,
      "amato_authored": false,
      "note": "The study directly compares metabolic health (insulin sensitivity) between women with lipedema (gynoid/peripheral fat distribution) and matched obese controls, finding significantly better insulin sensitivity in the lipedema group, which su",
      "title": "Adipose Tissue Biology and Effect of Weight Loss in Women With Lipedema",
      "authors": "Cifarelli et al.",
      "journal": "Diabetes",
      "grade": "moderate",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": false,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "Human review: synthesis — metabolic specifics (HbA1c/adiponectin/21 inflammatory proteins) are from a sibling proteomic source; already refines. Accepted.",
        "date": "2026-06-10",
        "reviewed_by": "Amato (ORCID 0000-0003-4008-4029)",
        "reviewed_date": "2026-06-12"
      },
      "quote": "people with Obese-LIP had ∼23% greater leg fat mass, ∼11% lower android-to-gynoid ratio, and ∼48% greater insulin sensitivity (all P < 0.05) than women matched on age, BMI, and whole-body adiposity",
      "extraction_confidence": "high",
      "stance_in_source_claim": "refines",
      "finding": "Women with obesity and lipedema had ~23% greater leg fat mass, ~11% lower android-to-gynoid ratio and ~48% greater insulin sensitivity than women matched on age, BMI and whole-body adiposity.",
      "from_claims": [
        "SCR-LIP-000108"
      ]
    },
    {
      "ref": "DOI:10.3389/fcell.2025.1691161",
      "stance": "context",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2025,
      "amato_authored": false,
      "note": "Narrative review synthesizing evidence that lipedema's peripheral/gynoid fat shows a metabolically favorable profile (preserved insulin sensitivity, low diabetes/dyslipidemia prevalence, anti-inflammatory M2 bias), which supports the affirm [grade capped low->very_low per curated Oxford N6]",
      "title": "Lipedema and adipose tissue: current understanding, controversies, and future directions",
      "authors": "Rabiee",
      "journal": "Frontiers in Cell and Developmental Biology",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article abstract explicitly reports the 'healthy expansion' hypothesis with the specific figures cited: 48% higher insulin sensitivity in obese lipedema patients, HbA1c 5.55% vs 6.73%, ~5% diabetes prevalence, ~7% dyslipidemia, and M2 m",
        "date": "2026-06-10"
      },
      "quote": "razões android-ginoide menores e sensibilidade à insulina preservada vs. controles pareados por IMC (Nankam et al., 2022); apesar do IMC elevado, prevalência de diabetes de apenas 5% e de dislipidemia de 7%; pacientes obesas com lipedema mostram sensibilidade à insulina 48% maior; HbA1c menor (5,55%",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Review reports preserved insulin sensitivity (48% higher in obese lipedema), lower HbA1c, low diabetes (~5%) and dyslipidemia (~7%) prevalence, and M2 macrophage predominance in thigh fat.",
      "from_claims": [
        "SCR-LIP-000152"
      ],
      "secondary_of": "DOI:10.2337/db24-0890"
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [
    {
      "name": "Alexandre C. M. Amato",
      "orcid": "0000-0003-4008-4029",
      "role": "lead_curator"
    }
  ],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000027",
    "SCR-LIP-000108",
    "SCR-LIP-000152"
  ],
  "questions_consolidated": [
    "SQ-LIP-000010"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00239",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000010"
    }
  ],
  "statement_pt": "O lipedema e a distribuição periférica de gordura semelhante à do lipedema podem estar associados a maior sensibilidade à insulina do que a obesidade comparável, embora os achados sejam mistos.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000010",
      "role": "supporting",
      "question": "Does a lipedema-like (peripheral/gynoid) fat distribution protect against cancer or metabolic disease?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000010.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000627.html"
}